Similarly, miR-138 promotes MM cancer stem cell survival by repressing PAX5, a tumor suppressor transcription factor; its inhibition via antagomirs restores PAX5 expression, reducing clonogenicity and drug resistance [195]. Here, PAX5 is linked to Miyoshi myopathy.